Font Size: a A A
Keyword [epidermal growth factor receptor-tyrosine kinase inhibitors]
Result: 1 - 20 | Page: 1 of 2
1. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (gefitinib) In China With Advanced Non-small Cell Lung Cancer Patients In The Efficacy And Safety Studies And Clinical Efficacy Predictors
2. The Effects Of Combined Administration Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Cytotoxic Drugs In Different Tumor Cell Lines
3. Cloning And Expression Of Human Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Screening Model To Build
4. The Important Role Of T790M And EMT In Prognosis Of Chemotherapy In NSCLC With Acquired Resistance Of EGFR-TKI
5. Design,Synthesis And Biological Activity Evaluation Of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
6. Recurrence Patterns In Patients With Advanced Non-small Cell Lung Cancer After Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
7. RCTs Tyrosine Kinase Inhibitor Medical Treatment Related To The Rash Of Epidermal Growth Factor Receptor
8. Individualized Therapy Of Advanced Non-small Cell Lung Cancer With Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
9. Docetaxel Versus EGFR-TKIs As Second-line Treatment Of Patients With Advanced Non-small-cell-lung Cancer
10. Study On The Structure Activity Relationship Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
11. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In The Treatment Of Central Nerve System Metastases From Non-Small Cell Lung Cancer
12. The Function Of FBW7 In The Development Of Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-small Cell Lung Cancer
13. Study Of The Sensitivity To EGFR-TKI Modulated By P53 On Triple-negative Breast Cancer Cells
14. The Role Of Cancer Stem Cells In EMT-induced Acquired Resistance To EGFR-TKIs In NSCLC Cells
15. Efficacy Of EGFR-Tyrosine Kinase Inhibitors And Clinical Pathologic Features Analysis Between Exon 19 Deletion And L858R Mutation With Advanced Non-Small Cell Lung Cancer
16. The Role Of Autophagy In Modulation Of Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-small Cell Lung Cancer
17. Study Of 18F-FEA-erlotinib As An EGFR Targeting PET Imaging Agent
18. Intercalated Combination Of Chemotherapy And EGFR-TKIs Versus Chemotherapy Alone In The First-line Treatment Of Advanced Non-small Cell Lung Cancer: A Meta-analysis
19. Correlation Of EGFR Mutation With Brain Metastases In Non-small Cell Lung Cancer
20. Role Of EMT In Radiosensitivity Of NSCLC With Acquired Resistance Of EGFR-TKI
  <<First  <Prev  Next>  Last>>  Jump to